Impact of intracoronary transplantation of mononuclear bone marrow stem cells on diastolic function in patients with acute myocardial infarction;Wpływ dowieńcowej transplantacji komórek macierzystych szpiku kostnego na funkcje rozkurczowa u pacjentów z zawałem mieśnia sercowego

Polski Przeglad Kardiologiczny

Volumn 11, Issue 4, 2009, Pages 249-254

  Plewka, Michał ^a   Krzemińska Pakuła, Maria ^a   Lipiec, Piotr ^a   Peruga, Jan Zbigniew ^a   Jezewski, Tomasz ^a   Kurpesa, Małgorzata ^a   Korycka, Anna ^b   Robak, Tadeusz ^b   Kasprzak, Jarosław Damian ^a  

^a II Katedra i Klinika Kardiologii   (Poland)

^b NONE   (Poland)

Author keywords

Bone marrow stem cells; Diastolic function; Myocardial infarction

Indexed keywords

EID: 77951966189     PISSN: 15075540     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Albanese MC, Plewka M, Gregori D, i wsp. Use of medical resources and quality of life of patients with chronic heart failure: a prospective survey in a large Italian community hospital. Eur J Heart Fail. 1999;1:411-417.
2. Strauer BE, Brehm M, Zeus T, i wsp. Repair of infarcted myocardium by autologous intracoronary mononuclear bone mnow cell transplantation in humans. Circulation. 2002;106:1913-1918.
3. Menasché P, Hagège AA, Vilquin JT, i wsp. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol. 2003;41:1078-1083.
4. Dowell JD, Rubart M, Pasumarthi KB, i wsp. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res. 2003;58,336-350.
5. Martin-Rendon E, Brunskill SJ, Hyde CJ, i wsp. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J. 2008;29,1807-1818.
6. Janssens S, Dubois C, Bogaert J, i wsp. Autologous bone marrow derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2005;367:113-121.
7. Chien KR. Stem cells: lost in translation. Nature. 2004;428,607-608.
8. Tendera M, Wojakowski W, Ruzyłło W, i wsp. Intracoronary infusion of bone marrow-derived selected CD34+CXCR+cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J. 2009;30:1313-1321.
9. Schächinger V, Erbs S, Elsässer A, i wsp. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J. 2006;27:2775-2783.
10. Lipinski MJ, Biondi-Zoccai GG, Abbate A, i wsp. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infaraion: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol. 2007;50:1761-1767.
11. Lipiec P, Krzemińska-Pakula M, Plewka M, i wsp. Impact of intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction on left ventricular perfusion and function: a 6-month follow-up gated 99mTc-MIBI single-photon emission computed tomography study. Eur J Nucl Med Mol Imaging. 2009;36:587-593.
12. Plewka M, Krzemińska-Pakuła M, Jez•ewski T, i wsp. Early echocardiographic assessment of coronary flow reserve after intracoronary administration of bone marrow stem cells in patients with myocardial infarction. Pol J Cardiol. 2008; 10:48-53.
13. Lang RM, Bierig M, Devereux RB, i wsp. Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
14. Korycka A, Plewka M, Krawczńska A, i wsp. The evaluation of efficacy of bone marrow CD34+ and CD133+ cells isolated from patients with acute myocardial infarction. Acta Haematologica Polonica. 2008;39:73-86.
15. Abdel-Latif A, Bolli R, Tleyjeh IM, i wsp. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007;167,989-997.
16. Kuznetsova T, Herborts L, López B, i wsp. Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail. 2009;2:105-112
17. Anversa P, Cheng W, Liu Y, i wsp. Apoptosis and myocardial infarction. Basic Res Cardiol. 1998;93 supl. 3:8-12.
18. Kieken F, Mutsaers N, Dolmatova E, i wsp. Structural and molecular mechanisms of gap junction remodeling in epicardial border zone myocytes following myocardial infarction. Circ Res. 2009;104:1103-1112.
19. Duncker DJ, Boontje NM, Merkus D, i wsp. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling. Circ Heart Fail. 2009;2:233-242.
20. Carrabba N, Parodi G, Valenti R, i wsp. Comparison of effects of primary coronary angioplasty on left ventricular remodeling and heart failure in patients lt;70 versus> or =70 years with acute myocardial infarction. Am J Cardiol. 2009;104:926-931.
21. Tse HF, Kwong YL. Chan JK, i wsp. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003; 361, 47-49.
22. Thompson CA, Nasseri BA, Makower J, i wsp. Percutaneous transvenous cellular cardiomyoplasty: a novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol 2003;41, 1964-1971.
23. Smits PC, van Geuns RJ, Poldermans D, i wsp. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure clinical experience with six-month follow-up. J Am Coll Cardiol. 2003:42,2063-2069.
24. Wojakowski W, Tendera M, Michałowska A, i wsp. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation. 2004;110,3213-3220.
25. Uemura R, Xu M, Ahmad N, Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res. 2006;98, 1414-1421.
26. Pagani FD, DerSimonian H, Zawadzka A, i wsp. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans: histological analysis of cell survival and differentiation. J Am Coll Cardiol. 2003;41,879-888.
27. Wierzbowska-Drabik K, Droz•dz• J, Plewka M, i wsp. The utility of pulsed tissue Doppler parameters for the diagnosis of advanced left ventricular diastolic dysfunction. Echocardiography. 2006;23:189-196.
28. Schaefer A, Meyer GP, Fuchs M, i wsp. Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial. Eur Heart J. 2006;27:929-935.
29. Wierzbowska-Drabik K, Krzemińska-Pakula M, Chrzanowski Ł, i wsp. Age-dependency of classic and new parameters of diastolic function. Echocardiography. 2008,25:149-155.
30. Celic VP, Dekleva MN, Kostic ND, i wsp. Velocity propagation of early diastole is a valuable tool for left ventricular remodelling after the first myocardial infarction. Coron Artery Dis. 2009;20:124-129.
31. Ommen SR, Nishimura RA, Appleton CP, i wsp. Clinical utility of Doppler echocardiography and tissue Doppler Imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler- catheterization study. Circulation. 2000;102:1788-1794.
32. Ueno Y, Nakamura Y, Kinoshita M, i wsp. An eariy predictor of left ventricular remodeling after reperfused anterior acute myocardial infarction: ratio of peak E wave velocity/flow propagation velocity and mitral E wave deceleration time. Echocardiography. 2002:19:555-563.